Victory Capital Management
ABUS icon

Victory Capital Management’s Arbutus Biopharma ABUS Stock Holding History

Victory Capital Management’s Portfolio ABUS Stock Details ABUS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-13,810
Closed -$28K – 2537
2023
Q3 		$28K Buy
13,810
+815
+6% +$1.71K ﹤0.01% 2428
2023
Q2 		$29.9K Sell
12,995
-302
-2% -$786 ﹤0.01% 2426
2023
Q1 		$40.3K Buy
+13,297
New +$37.5K ﹤0.01% 2461
2018
Q4 		– Sell
-151,060
Closed -$1.43M – 1778
2018
Q3 		$1.43M Sell
151,060
-7,660
-5% -$76.1K ﹤0.01% 1184
2018
Q2 		$1.16M Sell
158,720
-8,430
-5% -$50.2K ﹤0.01% 1218
2018
Q1 		$836K Buy
167,150
+16,430
+11% +$87K ﹤0.01% 1274
2017
Q4 		$761K Buy
150,720
+21,460
+17% +$126K ﹤0.01% 1273
2017
Q3 		$801K Sell
129,260
-3,550
-3% -$15.2K ﹤0.01% 1259
2017
Q2 		$478K Buy
+132,810
New +$457K ﹤0.01% 1319

Other funds holding ABUS

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
WCM
Whitefort Capital Management New York $339M AUM 52.48% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
TSC
Two Seas Capital Rye, New York $7.15B AUM 169.27% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
Hudson Bay Capital Management
Hudson Bay Capital Management Stamford, Connecticut $29B AUM 30.2% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return